These medications , copyright and Semaglutide, are becoming popular for treating type 2 diabetes and, more recently, excess weight. They both fall under a class of therapies called GLP-1 receptor agonists . https://what-is-glp1393045.newsyblog.com/1085808/understanding-copyright-semaglutide-and-glp-1-a-thorough-guide